Allison Jeynes-Ellis
Director/Board Member presso AGENUS INC.
Patrimonio netto: 38 382 $ in data 31/03/2024
Profilo
Allison M.
Jeynes-Ellis is currently the Chief Executive Officer at Avillion LLP since 2014.
She is also an Independent Director at Agenus, Inc. since 2018.
Additionally, she holds director positions at Siolta Therapeutics, Inc. and Anaveon AG.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
AGENUS INC.
0.02% | 01/03/2024 | 66 176 ( 0.02% ) | 38 382 $ | 31/03/2024 |
Posizioni attive di Allison Jeynes-Ellis
| Società | Posizione | Inizio |
|---|---|---|
| AGENUS INC. | Director/Board Member | 07/11/2018 |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Chief Executive Officer | 01/01/2014 |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Director/Board Member | - |
Siolta Therapeutics, Inc.
 Siolta Therapeutics, Inc. BiotechnologyHealth Technology Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AGENUS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
Siolta Therapeutics, Inc.
Siolta Therapeutics, Inc. BiotechnologyHealth Technology Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA. | Health Technology |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Allison Jeynes-Ellis
